Mitchell J Elliott

10PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersMolecular targetsBiomaterialsTe hauora me te oranga ā-whaea, ā-pēpi o te Māori (Māori mothers and babies health and wellbeing)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 16, 2026
A chromatin-informed transcriptional regulatory framework to stratify patients and guide therapy selection in triple-negative breast cancer.

|Jun 10, 2026
Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer.

|Jun 04, 2026
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy.

|Jun 04, 2026
Detecting ctDNA Using Personalized Structural Variants to Forecast Recurrence in Localized Soft-Tissue Sarcoma.

|May 13, 2026
Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed Assay.

|Feb 21, 2025
Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assay.

Mitchell J Elliott, Philippe Echelard, Christodoulos Pipinikas

Pageof 2

Frequent Collaborators

9 joint publications

David W Cescon

4 joint publications

Philippe L Bedard

4 joint publications

Lillian L Siu

2 joint publications

Sasha Main